GlassScriptPhysician profile
Cynthia J Devine
NPI 1730579426
$1,457.56
in general payments reported to CMS, 2019-2025
26 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $694 · 2022: $310 · 2023: $164 · 2024: $37.28 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $221.52 | 2021-2025 | Amvia Edge, Biomonitor |
| Astrazeneca Pharmaceuticals LP | $209.04 | 2021-2023 | Lokelma, Farxiga |
| Vantive US Healthcare LLC | $104.90 | 2025 | |
| Mallinckrodt Hospital Products INC. | $95.93 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.04 | 2021 | |
| Janssen Pharmaceuticals, INC | $85.53 | 2021-2023 | Xarelto |
| Pfizer INC. | $83.07 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.61 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $64.99 | 2021 | |
| Edwards Lifesciences Corporation | $48.59 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $37.11 | 2025 | Austedo Xr |
| Silk Road Medical, INC. | $34.97 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Amgen INC. | $33.15 | 2022-2024 | Tavneos |
| Calliditas Therapeutics US INC. | $33.04 | 2025 | Tarpeyo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.68 | 2021-2025 | Jardiance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.02 | 2021 | |
| Daiichi Sankyo INC. | $24.25 | 2022 | |
| Abbott Laboratories | $21.03 | 2021 | |
| Esperion Therapeutics, INC. | $19.57 | 2021 | |
| Glaxosmithkline, LLC. | $18.87 | 2022 | |
| Boston Scientific Corporation | $18.35 | 2021 | |
| Impulse Dynamics (USA) INC. | $17.92 | 2021 | |
| Ani Pharmaceuticals, INC. | $16.04 | 2022 | |
| Baxter Healthcare | $14.98 | 2022 | |
| Acacia Pharma INC | $14.09 | 2021 | |
| Merck Sharp & Dohme LLC | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.